A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic Leukemia
Clinical trial NCT01558167 · COMPLETED
Trial details
- NCT number
- NCT01558167
- Sponsor
- German CLL Study Group
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2013-10-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.